Long-term Use of Continuous Subcutaneous Hydrocortisone Infusion Therapy in Patients with Congenital Adrenal Hyperplasia

BACKGROUND: In a phase 2 short-term (6 months) study of patients with congenital adrenal hyperplasia (CAH), continuous subcutaneous hydrocortisone infusion (CSHI) was found to be a safe, effective, and well-tolerated method of replacing cortisol with improved disease and patient related outcomes. OB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Endocrinol (Oxf)
Main Authors: Mallappa, Ashwini, Nella, Aikaterini A., Sinaii, Ninet, Rao, Hamsini, Gounden, Verena, Perritt, Ashley F., Kumar, Parag, Ling, Alexander, Liu, Chia-Ying., Soldin, Steven J., Merke, Deborah P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166869/
https://ncbi.nlm.nih.gov/pubmed/30003563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13813
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados